February 26, 2020 / 2:17 PM / a month ago

BRIEF-Endo Expects To Launch Cellulite Treatment In Q4 2020, If Approved

Feb 26 (Reuters) - Endo International PLC:

* ENDO EXEC SAYS WHILE OPIOID SETTLEMENTS ARE ONGOING, CO IS PREPARED TO LITIGATE, IF NECESSARY - CONF CALL

* ENDO EXEC SAYS EXPECT FY’20 STERILE INJECTABLES REVENUES TO GROW IN THE LOW TO MID SINGLE DIGIT PERCENTAGE RANGE- CONF CALL

* ENDO EXEC SAYS EXPECT TO LAUNCH CELLULITE TREATMENT IN Q4 2020, IF APPROVED - CONF CALL Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below